Effects of Fresh Frozen Plasma on Hematologic Parameters in Open Heart Surgery

Size: px
Start display at page:

Download "Effects of Fresh Frozen Plasma on Hematologic Parameters in Open Heart Surgery"

Transcription

1 Original article Effects of Fresh Frozen Plasma on Hematologic Parameters in Open Heart Surgery Mahmut Mustafa ULAŞ 1, Necmettin ÇOLAK 2, Kumral ERGUN 3, Gökhan LAFÇI 1, Hacı Alper UZUN 1, Adnan YALÇINKAYA 1, Ersin KADİROĞULLARI 1, Emre YAŞAR 1, Ömer Faruk ÇİÇEK 1, Kerim ÇAĞLI 1 1 Türkiye Yüksek Ihtisas Hospital Department of Cardiovascular Surgery, ANKARA 2 Fatih University Faculty of Medicine Department of Cardiovascular Surgery, ANKARA 3 Türkiye Yüksek Ihtisas Hospital Department of Cardiology, ANKARA ÖZET Açık kalp cerrahisinde taze donmuş plazmanın hematolojik parametreler üzerine etkisi Açık kalp cerrahisi yapılan hastalarda taze donmuş plazma (TDP) transfüzyonunun doza bağımlı olarak hematolojik parametrelere olan etkilerinin ve klinik bulgularının prospektif olarak belirlenmesi amaçlanmıştır. Hastalar intraoperatif veya postoperatif TDP ihtiyaçlarına göre iki gruba ayrıldı.grup A (n=68),0-2u arası, Grup B (n=32), 3 ve üzeri TDP kullanan hastalardan oluşturuldu. Preoperatif ve postoperative hematolojik parametreler analiz edildi ve karşılaştırıldı. Postoperatif dönemde ateş ve enfeksiyon mevcudiyeti, üre, alanine aminotranferaz (ALT) ve C-reaktif protein (CRP) düzeyleri incelendi ve gruplar arasındaki end-organ hasarı ile inflammatuar yanıtları karşılaştırıldı. Operasyon sonrasında, Hemoglobin (Hb), Hematokrit (Hct) düzeyleri ve platelet sayıları belirgin olarak azalmıştı. Lökosit sayısı ve nötrofil ile monosit oranları postoperative dönemde artarken, lenfosit, eozinofil ve bazofillerde belirgin derecede düşüklük mevcuttu. Gruplar karşılaştırıldığında; total lökosit sayıları ve eozinofil hariç diğer lökosit subtiplerinin sayısı Grup B de Grup A dan belirgin olarak daha azdı. Toplam hastaların %30 da 38ºC nin üzerine çıkabilen ateş tespit edildi, gruplar arasındaki oran benzerdi. Her ne kadar CRP, üre ve ALT seviyelerinde operasyon sonrasında her iki grupta da belirgin artış oluşsa da gruplar arasında parametlerin dikkatle incelenmesi ile anlamlı bir farklılık tespit edilemedi. Bu çalışmada postoperative dönemde 2U nin üzerinde verilen TDP transfüzyonunun postoperative lökositozu belirgin derecede azalttığı gözlenmiştir. Ancak lökositozdaki bu azalma end organ hasarı ile ilişkili inflamasyonun önlenmesinde beklenen klinik düzelmeyi sağlamamıştır. Anahtar Kelimeler: Açık kalp cerrahisi, taze donmuş plazma, lökosit ABSTRACT Fresh frozen plasma on open heart surgery To prospectively determine whether fresh frozen plasma transfusion affects hematologic parameters in a dose dependent manner in patients undergoing open heart surgery and its clinical significance. Patients were divided into two groups according to the total intra-and/or postoperative fresh frozen plasma (FFP) requirement. Patients who need 0 to 2 units were included in Group A (n=68) and 3 units in Group B (n=32). Preoperative and postoperative hematologic parameters were analyzed and compared between groups. Presence of postoperative fever, infection and level of urea, alanine aminotransferase (ALT) and C- reactive protein (CRP) were also evaluated and compared between groups for inflammatory response and end-organ injury. After operation, Hemoglobin (Hb), Hematocrit (Hct) level and mean platelet count were decreased significantly. Whereas white blood cells (WBC) count and numbers of neutrophil and monocyte in formulation were increased postoperatively, other types of WBC (lymphocyte, eosinophil and basophil) were decreased significantly. Comparison of the groups revealed that total count of WBCs and count of subtypes except for eosinophil were significantly smaller in Group B than in Group A. Fever>38ºC was observed in 30% of all patients with a similar rate between groups. Although level of CRP, urea and ALT in both groups increased significantly after operation, no significant difference was observed between groups with regard to these parameters. This study demonstrated that postoperative transfusion of >2 units of FFP can reduce postoperative leukocytosis significantly but it could not establish clinical improvement which would be expected as a result of the prevention of inflammation related end-organ injury Key Words: Open heart surgery, fresh frozen plasma and white blood cell INTRODUCTION Although recent advances in surgical techniques and perfusion technology decreased operative mortality of open heart surgery, bleeding disorders, thrombotic complications and the activation of blood components that are collectively known as systemic inflammatory response are still important problems of continuous blood purification (CPB). Exposure of blood to artificial surfaces of extracorporeal circuit and anomalous mechanical and environmental factors, such as high shear stress, turbulance, decreased oncotic pressure and hypothermia cause damage to blood elements, which is manifested by hemolysis, thrombocytopenia along with platelet dysfunction and reactivity of mononuclear cells 1-3. Currently prevention of these adverse effects by the means 169

2 of extracorporeal surface modifications, control of flow dynamics, pharmacological interventions and antinflammatory methods is an interesting subject of investigations. In this study we evaluated whether intra-and/or postoperative transfusion of fresh frozen plasma (FFP) in patients undergoing CPB has a hemoprotective role on white blood cells (WBCs) which may result in partial inhibition of inflammatory response and end organ injury. MATERIALS AND METHODS Our study was designed in prospective manner among 100 consecutive patients who underwent open heart surgery with CPB (coronary artery bypass grafting, valve surgery, or corrective surgery or repair for congenital defects). Patients who had transfusion of preoperative FFP or other blood products and postoperative whole blood, preoperative leukocytosis (over /mm 3 ) and angiographic procedures including radiocontrast administration within 15 days were excluded from the study. Study Analysis: Patient characteristics were noted down preoperatively. Intraoperative variables such as aortic cross-clamp period (XCl), total perfusion period (TPP) and degree of hypothermia and intraoperative and/or postoperative requirement of FFP were recorded for each patient. Patients were divided into two groups according to the dose of FFP need. Patients who required 0 to 2 units of FFP were included in Group A (n=68) and 3 units in Group B (n=32). The hematological parameters including hematocrite and hemoglobin level, platelet count and WBC count and formulation and level of C-reactive protein (CRP), urea and alanin amino transferase (ALT) were checked preoperatively and on the second postoperative day for comparison. Presence of postoperative fever (>38ºC) or infection that is confirmed by appropriate cultures were also noted down. Statistical analysis: Data obtained from the current study were evaluated by SPSS (Statistical Package for Social Sciences) 11-5 package program. Values were expressed as (mean) (standard deviation). Student-t (Paired and independent) and chi-square tests were used for statistical analysis. Paired sample t-test was used for analyzing of same groups before and after procedure. Independent samples t-test was used for analyzing of different groups. AP value of <0.05 was considered to indicate statistical significance. All statistical analyses were in the 95 % CI and performed on a personal computer with the statistical package SPSS for Windows. RESULTS Patient characteristics were given in Table 1. Sixty-five of patients were male and 35 were female. The mean age of all population was 54,3 22,3 years. Fifty-five patients had coronary artery bypass surgery, 34 had valve replacement surgery (18 mitral valve replacement, 8 aortic valve replacement, 7 double valve replacement) and 11 had repair or corrective operations for congenital heart disease. Intraoperative variables such as XCl, TPP and hypothermic degrees are given in Table 2. The mean degree of hypothermia was moderate and CPB duration was less than 150 minutes. In Table 3 number of patients according to the their requirement of intraoperative and/or postoperative FFP use are shown. Patients with transfusion less than 3 units are in Group A and 3 units are in Group B. Table 1. Patient characteristics Group A Group B P values Age(y) ±18.4 NS Sex(M/F) 44/24 20/12 NS Smoking 31(45,58%) 14(43,75%) NS Diabetes Mellitus 19(27,94%) 10(31,25%) NS Hypertension 37(54,41%) 17(53,12%) NS Coronary artery bypass grafting surgery 38(55,88%) 18(56,25%) NS Valvular surgery 23(33,82%) 11(34,37%) NS Congenital surgery 7(10,29%) 3(9,37%) NS NS:Not significant Table 2. Operative variables Group A Group B p values Cross-clamp (XCl) time (min) 38±19,05 42±16,23 NS Cardiopulmonary bypass time (min) 63,11±30,00 66,44±27,76 NS Hypothermia degree (ºC) 31,58±1,52 30,97±1,34 NS NS:Not significant 170

3 Table 3. FFP requirements and number of patients Fresh frozen Number of % plasma unit patient All hematologic parameters were changed significantly after open heart surgery for all patient cohort (Table 4). Mean Hb and Hct level were decreased from 13,4 3,98 g/dl to 8,34 1,95g/dl, p<0.001 and from 40,3 18,3% to 26,3 7,05%, p<0.001 respectively. Mean platelet count were also decreased significantly ( /μl vs /μl, p<0.001). Whereas WBC count and numbers of neutrophil and monocyte in formulation were increased postoperatively ( /μl vs /μl, p<0.001;4500± 613/μl vs 11593±2213/μl, p<0.001, and 400±116/μl vs 689±289/μl, p<0.001 respectively), other types of WBC (lymphocyte, eosinophil and basophil) were decreased significantly. Comparison of after transfusion value of total WBC count and WBC formulation between groups are shown in table 5. It revealed that total count of WBC and count of subtypes except for eosinophil were significantly smaller in Group B than in Group A. Postoperative infection was not observed in any patient but fever>38ºc was noted in 30% of all patient with a similar rate between two groups (24/68 vs 6/32, p>0.05). Level of CRP, urea and ALT in both groups increased significantly after operation (Table 6). Table 4. Hematologic changes with FFP administration in preoperative and postoperative period Preoperative Postoperative Parameters n Mean ± SD n Mean±SD p Hematocrit ± ±7 <0.001 Hemoglobin ± ±1.95 <0.001 Platelet ± ±45820 <0.001 White blood cell ± ±6820 <0.001 Neutrophil ± ±2213 <0.001 Lymphocyte ± ±857.8 <0.001 Monocyte ± ±289 <0.001 Eosinophil ± ±135 <0.001 Basophil ± ±23.5 <0.001 Table 5. Comparison of WBC counts and leucocyte formula after FFP administration Group A Group B Parameters n Mean ± SD n Mean±SD p White blood cell ± ± Neutrophil ± ±871.6 <0.001 Lymphocyte ± ± Monocyte ± ±220.6 <0.001 Eosinophil ± ± Basophil 68 42± ± Group A: 2 Units and lesser Group B: 3 and 4 Units Table 6. Levels of CRP, urea and ALT in both groups FFP Preoperative postoperative Parameter n Mean ± SD N Mean ± SD P (Pre-post-op CRP(mg/l)Total ± ±32.6 <0.001 Group A ± ±32.8 <0.001 Group B ± ±31.6 <0.001 p (Group A-B) Urea(mg/dl)Total <0.001 Group A <0.001 Group B <0.001 P(Group A-B) 0.007* 0.32 ALT(IU/I) Total <0.001 Group A <0.001 AGroup B <0.001 P(Group A-B) 0.024* 0.21 <0.001 Group A: 2 units and lesser CRP: C-reactive protein Group B: 3 and units ALT: Alanine aminotranferase 171

4 CRP level increased from 0.00 mg/l to mg/l in Group A (p<0.001) and from 0.00 mg/l to mg/l in group B (p<0.001). Increment of urea level is from to in Group A (p<0.001) and from to in Group B (p<0.001). ALT level also increased significantly in both Group A and Group B ( IU/l vs IU/l and IU/l vs IU/l, respectively). Although preoperative level of urea was significantly higher in Group A as ALT level in Group B, no significant difference was observed between groups with regard to these parameters after operation. DISCUSSION CPB, especially when prolonged, results in activation of the coagulation cascade, fibrinolytic system, complement system (by way of C3a and C5a), kallikrein-bradykinin system, activation of neutrophils with degranulation and protease enzyme release, oxygen radical production and the synthesis of various cytokines from mononuclear cells (including tumor necrosis factor-alpha, interleukin-1(il-1), IL-6, IL-8 4,5. These activated cascades result in a decrease in the number of circulating coagulation factors, hyperfibrinolysis, trombocytopenia, platelet defects, and an acute inflammatory response. In the most extreme form, this inflammation is associated with a generalised whole body postpump syndrome, characterised by increased capillary permeability, pulmonary edema, fever, leucocytosis, renal dysfunction and hemodynamic collapse. The post-cpb inflammatory response is a consequence of exposure of the blood to foreign surfaces during prolonged CPB and depends upon recruitment and activation of inflammatory cells. Leucocyte recruitment is a complex process that involves several protein families, including proinflammatory cytokine, adhesion molecules and chemokines 6. Especially activation of neutrophils with degranulation and protease enzyme release is a crucial step in inflammation and results in neutrophil sequestration within the tissues 7. Generation of the anaphylatoxins C3a and C5a mediates leucocyte chemotaxis, aggregation, and enzyme release 5,8,9. Sequestration of activated leucocytes and platelets in tissues, especially in lungs 10, occurs with attendant damage to the vascular integrity 11 and increase morbidity and mortality. There is a direct relationship between the duration of CPB and the development of post- CPB inflammatory response 12. Duration of CPB, level of proinflammatory cytokines and WBCs count are also longer and higher in patients with long lasting post-cpb inflammatory response 13. Currently recognition of the significance of this inflammatory response led to development of antiinflammatory therapies including aprotinin 14, inhibitors of the complement system 15, antiinflammatory cytokines such as interleukin-10 16, off-pump surgery 17, steroids 18, L-arginine 19 and leucocyte depletion techniques In this study we demonstrated that FFP transfused for hemostatic problems also reduces the postoperative leucocytosis in a dose dependent manner, which could reflect partial inhibition of post-cpb inflammation. All patients who undergo CPB develop a multifactorial derangement of the hemostatic system. These abnormalities are platelet dysfunction caused by exposure of the blood to artificial surfaces, hemodilution related thrombocytopenia 23 and coagulation factor depletion 24 and heparinization itself. Platelet dysfunction is the most significant hemostatic abnormality, although depletion of coagulation factors may have greater significance in patients with preoperative hemostatic deficiency. Although patients undergoing cardiac operations constitute the majority of recipients of FFP, in CPB surgery, FFP is only indicated in the presence of bleeding and disturbed coagulation 25 and routine use is widely advocated to avoid viral infections 26,27. This study demonstrated that intra-and/or postoperative transfusion of >2 units of FFP can reduce postoperative leukocytosis significantly but it could not establish clinical improvement which would be expected as a result of the prevention of inflammation related end-organ injury. Therefore larger studies including wider spectrum of endorgan injury and inflammatory response analysis, and morbidity and early postoperative mortality evaluation are needed before making a conclusion. REFERENCES 1. Hsu LC. Biocompatibility in cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997;11: Kameneva MV, Undar A, Antaki JF, Watach MJ, Calhoon JH, Borovetz HS. Decrease in red blood cell deformability caused by hypothermia, hemodilution and mechanical stress: factors related to cardiopulmonary bypass. ASAIO J. 1999;45: Hansbro SD, Sharpe DA, Catchpole R. Haemolysis during cardiopulmonary bypass: an in vivo comparison of standard roller pumps, nonocclusive roller pumps and centrifugal pumps. Perfusion 1999;14: Donahue MA, Price PM. Aprotinin : antifibrinolytic and antiinflammatory mechanism of action in cardiac surgery with cardiopulmonary bypass. Dynamics 2002;13: Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55: Ben-Abraham R, Weinbroum AA, Dekel B, Paret G. Chemokines and the inflammatory response following cardiopulmonary bypass- a new target for therapeutic intervention?- A review. Paediatr Anaesth 2003;13:

5 7. Al-Ruzzeh S, Hoare G, Marczin N, Asimakopoulos G, George S, Taylor K, Amrani M. Off-pump coronary artery bypass surgery is associated with reduced neutrophil activation as measured by the expression of CD11b: a prospective randomized study. Heart Surg Forum 2003;6: Svennevig J, Geiran O, Karlsen J. Complement activation during extracorporeal circulation: In vitro comparison of duraflo-ii heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1993;106: Shafique T, Jhonson R, Dai H. Altered pulmonary microvascular reactivity after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106: Ito H, Hamano K, Gohra H. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today 1997;27: vom Dahl J, Eitzman D, Al-Aouar z. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularisation. Circulation 1994;90: Lippmann M, Goldberg S, Walkenstein M. Pulmonary complications of open heart surgery. In Kotler M and Alfieri A (eds): Cardiac and Noncardiac Complications of Open Heart Surgery: prevention, Diagnosis, and Treatment. Mt. Kisco NY, Futura 1992; p Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 2003;9: Lei Y, Haider Hkh, Chusnsheng W. Dose dependent effect of aprotinin on aggravated pro-inflammatory cytokines in patients with pulmonary hypertension following cardiopulmonary bypass. Cardiovasc Drugs Ther 2003;17: Pugsley MK, Abramova M, Cole T, Yang X, Ammons WS. Inhibitors of the complement system currently in development for cardiovascular disease. Cardiovasc Toxicol 2003;3: Giomarelli P, Scolletta S, Borrelli E, Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin(il)-10. Ann Thorac Surg 2003;76: Biglioli P, Cannata A, Alamanni F, et al. Biological effects of offpump vs on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 2003;24: Gormley SM, Armstrong MA, McMurray TJ, McBride WT. The effect of methylprednisolone on cytokine concentration and leucocyte adhesion molecule expression in an isolated cardiopulmonary bypass system. Cytokine 2003;22: Dewanjee MK, Wu SM, De D. Reduction of neutrophil margination by L- arginine during hypothermic cardiopulmonary bypass in a pig model. ASAIO J 1996;42: Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Perfusion 2003;18: Samankatiwat P, Samartzis I, Lertsithichai P. Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies. Perfusion 2003;18: Ichihara T, Yasuura K, Maseki T. The effects of using a leucocyte removal filter during cold cardioplegia. Surg Today 1994;24: Cines DB, Tomaski A, Tannenbaum S. Immune endothelial cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987;316: Kajani M, Waxman H. Hematologic problems after open heart surgery. In Kotler M, Alfieri A(eds.): Cardiac and Noncardiac Complications of Open Heart Surgery: Prevention, Diagnosis, and Treatment. Mt. Kisco NY, Futura 1992, p Contreras M, Ala FA, Greaves M. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 1992;2: Consten EC, Henny CP, Eijsman L, Dongelmans DA, van Oers MH. The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg 1996;112: Schlayer HJ, Peters T, Preisler S, Berthold H, Gerok W, Rasenack J. Cause and frequency of posttransfusion hepatitis after open heart surgery. Clin Investig 1992;70: Correspondence: Mahmut Mustafa ULAŞ M.D. Yüksek Ihtisas Hospital Department of Cardiovascular Surgery, Ankara Arrival date : Acceptance date :

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, 2012 45 th Annual Great Lakes Cancer Nursing Conference Troy, MI Overview of Hematology, http://www.nu.edu.sa/userfiles/mhmorsy/h

More information

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized

More information

Blood Transfusion Therapy in Trauma and Massive Hemorrhage Putting the Patient First

Blood Transfusion Therapy in Trauma and Massive Hemorrhage Putting the Patient First FACULTY OF MEDICINE, DENTISTRY AND HEALTH SCIENCES Blood Transfusion Therapy in Trauma and Massive Hemorrhage Putting the Patient First ALBERT FARRUGIA Historical Background Over last 40 years, transfusion

More information

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9 Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Preoperative Laboratory and Diagnostic Studies

Preoperative Laboratory and Diagnostic Studies Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no

More information

Blood Sticky, opaque fluid with a metallic taste (Fe 2+ ) Varies from scarlet (P O2 = 100) to dark red (P O2 = 40) ph is between 7.35 and 7.45 Average volume in an adult is 5 L (7% of body weight) 2 L

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

VPM 152. INFLAMMATION: Chemical Mediators

VPM 152. INFLAMMATION: Chemical Mediators General Pathology VPM 152 INFLAMMATION: Chemical Mediators CHEMICAL MEDIATORS OF INFLAMMATION Definition: any messenger that acts on blood vessels, inflammatory cells or other cells to contribute to an

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

Sepsis: Identification and Treatment

Sepsis: Identification and Treatment Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge

More information

Interpretation of Laboratory Values

Interpretation of Laboratory Values Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances

More information

Guideline Statement for the Treatment of Disseminated Intravascular Coagulation

Guideline Statement for the Treatment of Disseminated Intravascular Coagulation Guideline Statement for the Treatment of Disseminated Intravascular Coagulation Introduction Though a rare occurrence in the perioperative setting, disseminated intravascular coagulation (DIC) is a syndrome

More information

Inflammation and Healing. Review of Normal Defenses. Review of Normal Capillary Exchange. BIO 375 Pathophysiology

Inflammation and Healing. Review of Normal Defenses. Review of Normal Capillary Exchange. BIO 375 Pathophysiology Inflammation and Healing BIO 375 Pathophysiology Review of Normal Defenses Review of Normal Capillary Exchange 1 Inflammation Inflammation is a biochemical and cellular process that occurs in vascularized

More information

Introduction to Blood Management

Introduction to Blood Management Introduction to Blood Management What is Blood Management? Preventing a blood transfusion to the patient who doesn t need one Right blood product, at the right time, in the right dose, to the right patient

More information

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions. KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term

More information

Blood. Functions of Blood. Components of Blood. Transporting. Distributing body heat. A type of connective tissue. Formed elements.

Blood. Functions of Blood. Components of Blood. Transporting. Distributing body heat. A type of connective tissue. Formed elements. Blood Functions of Blood Transporting nutrients respiratory gases waste products Distributing body heat Components of Blood A type of connective tissue Formed elements Living blood cells Plasma Nonliving

More information

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies Overview Where We Use It And Why Andreas Antoniou, M.D., M.Sc. Department of Anesthesia and Perioperative Medicine University of Western Ontario November 14 th, 2009 Hemostasis Fibrinolysis Aprotinin and

More information

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood Thibodeau: Anatomy and Physiology, 5/e Chapter 17: Blood This chapter begins a new unit. In this unit, the first four chapters deal with transportation one of the body's vital functions. It is important

More information

Emergency Cardiac Surgery in Pregnancy and Post-partum Women

Emergency Cardiac Surgery in Pregnancy and Post-partum Women Emergency Cardiac Surgery in Pregnancy and Post-partum Women Phillips B. Harrington MD, Chris Piercecchi MD, Elise Bardawil MD, Jose Binongo PhD, Omar Lattouf MD 2-28-2016 Emory University Division of

More information

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University

More information

Platelet Review July 2012. Thomas S. Kickler M.D. Johns Hopkins University School of Medicine

Platelet Review July 2012. Thomas S. Kickler M.D. Johns Hopkins University School of Medicine Platelet Review July 2012 Thomas S. Kickler M.D. Johns Hopkins University School of Medicine Hemostasis Hemostasis is the process that leads to the stopping of bleeding Hemostasis involves blood vessels,

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

Blood. The only fluid tissue in the human body. Classified as a connective tissue

Blood. The only fluid tissue in the human body. Classified as a connective tissue Blood The only fluid tissue in the human body Classified as a connective tissue Blood If blood is centrifuged Erythrocytes sink to the bottom Buffy coat contains leukocytes and platelets Buffy coat is

More information

Pharmacology of the Respiratory Tract: COPD and Steroids

Pharmacology of the Respiratory Tract: COPD and Steroids Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

The Cardiovascular System: Blood

The Cardiovascular System: Blood Essentials of Anatomy & Physiology, 4th Edition Martini / Bartholomew The Cardiovascular System: Blood PowerPoint Lecture Outlines prepared by Alan Magid, Duke University Slides 1 to 54 The Functions of

More information

Care of the Post-Cardiac Surgery Patient. Lundy J. Campbell, M.D. Associate Professor University of California

Care of the Post-Cardiac Surgery Patient. Lundy J. Campbell, M.D. Associate Professor University of California Care of the Post-Cardiac Surgery Patient Lundy J. Campbell, M.D. Associate Professor University of California Post-Operative Issues Post-op atrial fibrillation Acute kidney injury Acute respiratory failure

More information

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1 AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL

More information

Clinical Practice Assessment Robotic surgery

Clinical Practice Assessment Robotic surgery Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

Hepatitis C. Laboratory Tests and Hepatitis C

Hepatitis C. Laboratory Tests and Hepatitis C Hepatitis C Laboratory Tests and Hepatitis C If you have hepatitis C, your doctor will use laboratory tests to check your health. This handout will help you understand what the major tests are and what

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

ABO-Rh Blood Typing Using Neo/BLOOD

ABO-Rh Blood Typing Using Neo/BLOOD ABO-Rh Blood Typing Using Neo/BLOOD Objectives Determine the ABO and Rh blood type of unknown simulated blood samples. Prepare a simulated blood smear. Examine a prepared blood smear under the microscope

More information

Denominator Statement: Cardiac surgery patients with no evidence of prior infection.

Denominator Statement: Cardiac surgery patients with no evidence of prior infection. Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)

More information

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali

More information

SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES

SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES SARASOTA MEMORIAL HOSPITAL BLOOD COMPONENT CRITERIA AND INDICATIONS SCREENING GUIDELINES TABLE OF CONTENTS SUBJECT PAGE ADULT CRITERIA Red Blood Cells/Autologous 2 Washed Red Blood Cells 2 Cryoprecipitate

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY BLOOD CONSERVATION STRATEGIES IN CARDIAC SURGERY: MORE IS BETTER GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY DIMITRIOS V. AVGERINOS MD, PhD, FACS, FACC Department of Cardiac Surgery,

More information

Human Clinical Study for Free Testosterone & Muscle Mass Boosting

Human Clinical Study for Free Testosterone & Muscle Mass Boosting Human Clinical Study for Free Testosterone & Muscle Mass Boosting GE Nutrients, Inc. 920 E. Orangethorpe Avenue, Suite B Anaheim, California 92801, USA Phone: +1-714-870-8723 Fax: +1-732-875-0306 Contact

More information

3. The Circulatory System

3. The Circulatory System 3. The Circulatory System A. Introduction B. Blood 1. Circulatory system transports water, electrolytes, hormones, enzymes, antibodies, cell, gases and nutrients to all cells and carries away metabolic

More information

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire

Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire Date: RPICC Facility: CMS use only Include the following

More information

Phlebotomy Handbook Blood Collection Essentials Seventh Edition

Phlebotomy Handbook Blood Collection Essentials Seventh Edition Phlebotomy Handbook Blood Collection Essentials Seventh Edition Diana Garza Kathleen Becan-McBride Chapter Four The Cardiovascular System Introduction Circulatory system is a transport system. Contributes

More information

INTRODUCTION TO EECP THERAPY

INTRODUCTION TO EECP THERAPY INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and

More information

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting

More information

R EFERENCES. Summary and conclusions

R EFERENCES. Summary and conclusions R EFERENCES Summary and conclusions 129 S UMMARY AND CONCLUSIONS SUMMARY AND GENERAL DISCUSSION 130 Constant vasodilatation, inhibition of platelet and monocyte adhesion, and local thrombolysis are the

More information

Thoracoabdominal aortic aneurysm

Thoracoabdominal aortic aneurysm Thoracoabdominal aortic aneurysm Patient (1) - 69 PMH: 2013 - MVP, aortic root replacement with biological valve (Perimount) and subtotal aortic arch replacement Analysis for oppressive chest complaints

More information

Advanced Heart Failure & Transplantation Fellowship Program

Advanced Heart Failure & Transplantation Fellowship Program Advanced Heart Failure & Transplantation Fellowship Program Curriculum I. Patient Care When on the inpatient Heart Failure and Transplant Cardiology service, the cardiology fellow will hold primary responsibility

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions.

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions. OBJECTIVES: 1. Describe blood according to its tissue type and major functions. 2. Define the term hematology. 3. Name the average volume of blood in a human. 4. Name the two major components of blood

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulant

More information

37 2 Blood and the Lymphatic System Slide 1 of 34

37 2 Blood and the Lymphatic System Slide 1 of 34 1 of 34 Blood is a connective tissue that contains both dissolved substances and specialized cells. 2 of 34 The functions of blood include: collecting oxygen from the lungs, nutrients from the digestive

More information

4. is an increased rate of red blood cell destruction. A) Sickle-cell disease B) Hemolytic anemia C) Pernicious anemia Ans: B

4. is an increased rate of red blood cell destruction. A) Sickle-cell disease B) Hemolytic anemia C) Pernicious anemia Ans: B Chapter 11: Blood 1. The hematocrit is composed mainly of A) plasma. B) white blood cells. C) platelets. D) red blood cells. 2. Fifty-five percent of blood is A) liquid. B) plasma. C) formed elements.

More information

Journal of Clinical and Basic Cardiology

Journal of Clinical and Basic Cardiology Journal of Clinical and Basic Cardiology An Independent International Scientific Journal Journal of Clinical and Basic Cardiology 2005; 8 (1-4), 33-36 Production of Reactive Oxygen Species and Antioxidant

More information

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

Final Exam Study Guide Objectives Health Sciences 2230

Final Exam Study Guide Objectives Health Sciences 2230 Final Exam Study Guide Objectives Health Sciences 2230 UNIT 1 Chapter 2 Altered Cellular and Tissue Biology 1. Compare and contrast the adaptive and maladaptive cellular adaptations: atrophy, hypertrophy,

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Leukemias and Lymphomas: A primer

Leukemias and Lymphomas: A primer Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes

More information

Introduction. Pathogenesis of type 2 diabetes

Introduction. Pathogenesis of type 2 diabetes Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic

More information

Perioperative management for Diabetes Mellitus. Dr. Khor Hong Tar Consultant Endocrinologist NTFGH

Perioperative management for Diabetes Mellitus. Dr. Khor Hong Tar Consultant Endocrinologist NTFGH Perioperative management for Diabetes Mellitus Dr. Khor Hong Tar Consultant Endocrinologist NTFGH Outline Physiology Why worry? Glycemic goal New evidence General principles Physiology Altered oral intake

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Human Anatomy & Physiology II with Dr. Hubley

Human Anatomy & Physiology II with Dr. Hubley Human Anatomy & Physiology II with Dr. Hubley Exam #1 Name: Instructions This exam consists of 40 multiple-choice questions. Each multiple-choice question answered correctly is worth one point, and the

More information

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Low Molecular Weight Heparin All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Starting Point Low Molecular Weight Heparin (LMWH): Inhibits factor Xa and factor IIa (thrombin) Small

More information

Thrombin Formation for Children on Lovenox. Steven Ignell, BA

Thrombin Formation for Children on Lovenox. Steven Ignell, BA Thrombin Formation for Children on Lovenox Steven Ignell, BA Definitions Anticoagulation Historically this refers to inhibiting thrombin formation Measured by PTT, INR, anti-xa Hypo and hypercoagulation

More information

Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN

Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN Learning Outcomes Identify triggers to the IIR. Describe the pathophysiologic changes that

More information

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein WLHS/A&P/Oppelt Name Lymphatic System Practice 1. Figure 12-1 provides an overview of the lymphatic vessels. First color code the following structures. Color code in Figure 12-1 Heart Veins Lymphatic vessels/lymph

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

12.1: The Function of Circulation page 478

12.1: The Function of Circulation page 478 12.1: The Function of Circulation page 478 Key Terms: Circulatory system, heart, blood vessel, blood, open circulatory system, closed circulatory system, pulmonary artery, pulmonary vein, aorta, atrioventricular

More information

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach. Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight

More information

What Do Those Lab Tests Mean?

What Do Those Lab Tests Mean? What Do Those Lab Tests Mean? This information is not meant to be a substitute for veterinary care. Always follow the instructions provided by your veterinarian. The results of laboratory tests on a patient

More information

Common Surgical Procedures in the Elderly

Common Surgical Procedures in the Elderly Common Surgical Procedures in the Elderly From hip and knee replacements to cataract and heart surgery, America s elderly undergo 20% of all surgical procedures. For a group that comprises only 13% of

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

CARDIAC CARE. Giving you every advantage

CARDIAC CARE. Giving you every advantage CARDIAC CARE Giving you every advantage Getting to the heart of the matter The Cardiovascular Program at Northwest Hospital & Medical Center is dedicated to the management of cardiovascular disease. The

More information

Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting

Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting Federico Bizzarri, MD Sabino Scolletta, MD Enrico

More information

Department of Surgery

Department of Surgery What is emphysema? 2004 Regents of the University of Michigan Emphysema is a chronic disease of the lungs characterized by thinning and overexpansion of the lung-like blisters (bullae) in the lung tissue.

More information

Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods

Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods Blood Products Advisory Committee, March 9, 2006 Steven Kleinman, MD Senior Medical Advisor, AABB Co-chair, AABB

More information

Albumin. Prothrombin time. Total protein

Albumin. Prothrombin time. Total protein Hepatitis C Fact Sheet February 2016 www.hepatitis.va.gov Laboratory Tests and Hepatitis If you have hepatitis C, your doctor will use laboratory tests to about learn more about your individual hepatitis

More information

Determinants of duration of ICU stay after coronary artery bypass graft surgery

Determinants of duration of ICU stay after coronary artery bypass graft surgery British Journal of Anaesthesia 1996; 77: 208 212 Determinants of duration of ICU stay after coronary artery bypass graft surgery A. MICHALOPOULOS, G. TZELEPIS, G. PAVLIDES, J. KRIARAS, U. DAFNI AND S.

More information

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL DOCTORATE THESIS. - Summary

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL DOCTORATE THESIS. - Summary UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL DOCTORATE THESIS - Summary CHRONIC COMPLICATIONS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS - Epidemiological study - PhD Manager: Professor PhD.

More information

Antiplatelet and Antithrombotics From clinical trials to guidelines

Antiplatelet and Antithrombotics From clinical trials to guidelines Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories

More information

F.E.E.A. FONDATION EUROPEENNE D'ENSEIGNEMENT EN ANESTHESIOLOGIE FOUNDATION FOR EUROPEAN EDUCATION IN ANAESTHESIOLOGY

F.E.E.A. FONDATION EUROPEENNE D'ENSEIGNEMENT EN ANESTHESIOLOGIE FOUNDATION FOR EUROPEAN EDUCATION IN ANAESTHESIOLOGY créée sous le Patronage de l'union Européenne Detailed plan of the program of six courses 1. RESPIRATORY 1. ESPIRATORY AND THORAX 1.1 Physics and principles of measurement 1.1.1 Physical laws 1.1.2 Vaporizers

More information

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,

More information

ELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS

ELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS ELSO GUIDELINES FOR TRAINING AND CONTINUING EDUCATION OF ECMO SPECIALISTS PURPOSE The "" is a document developed by the Extracorporeal Life Support Organization (ELSO) as a reference for current and future

More information

Summary & Conclusion

Summary & Conclusion The prognostic value of angiogenesis markers in patients with non-hodgkin lymphoma. Summary & Conclusion The current study aims to asses the prognostic value of some angiogenesis markers in patients with

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare

More information

GT-020 Phase 1 Clinical Trial: Results of Second Cohort

GT-020 Phase 1 Clinical Trial: Results of Second Cohort GT-020 Phase 1 Clinical Trial: Results of Second Cohort July 29, 2014 NASDAQ: GALT www.galectintherapeutics.com 2014 Galectin Therapeutics inc. Forward-Looking Statement This presentation contains, in

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

Sepsis and the Clinical Laboratory

Sepsis and the Clinical Laboratory Sepsis and the Clinical Laboratory Alison Woodworth, PhD Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville, TN Learning Objectives Outline the Pathogenesis

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

Surgical Mitral Valve Repair The Gold Standard. A. Marc Gillinov, M.D.

Surgical Mitral Valve Repair The Gold Standard. A. Marc Gillinov, M.D. Surgical Mitral Valve Repair The Gold Standard A. Marc Gillinov, M.D. Disclosures Speaker/consultant Edwards Lifesciences Onyx Lifesciences Research support St. Jude Medical Medtronic A Common Case A Common

More information

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) S. Agarwal, MD, S. Kache MD

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) S. Agarwal, MD, S. Kache MD ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) S. Agarwal, MD, S. Kache MD Definition ARDS is a clinical syndrome of lung injury with hypoxic respiratory failure caused by intense pulmonary inflammation that

More information

Cardiovascular System. Blood Components

Cardiovascular System. Blood Components Cardiovascular System Blood Components 1 Components of Blood Formed elements: erythrocytes, leukocytes, platelets Plasma: water, proteins, other solutes The components of blood can be divided into two

More information